Glucocorticoid group | Control group | ASMD | |
---|---|---|---|
Number of participants, n | 203 | 203 | |
Age(years), median [25th–75th percentiles] | 52 [41, 64] | 50 [35, 66] | 0.08 |
Sex, female, n (%) | 131 (64.5) | 127 (62.6) | 0.04 |
Charlson comorbidity index, median [25th–75th percentiles] | 1 [0, 1] | 1 [0, 1] | < 0.01 |
Vasoactive-Inotropic Score (VIS), median [25th–75th percentiles] | 0 [0, 0] | 0 [0, 0] | 0.08 |
Consciousness, alert, n (%) | 57 (50.0) | 56 (50.0) | 0.03 |
Defibrillation, n (%) | 6 (3.0) | 6 (3.0) | < 0.01 |
Mechanical ventilation use, n (%) | 57 (28.1) | 52 (25.6) | 0.06 |
Renal replacement therapy, n (%) | 6 (3.0) | 4 (2.0) | 0.06 |
Extra-corporeal membrane oxygenation, n (%) | 4 (2.0) | 3 (1.5) | 0.05 |
Intra-aortic balloon pump, n (%) | 4 (2.0) | 4 (2.0) | < 0.01 |
Acetaminophen use, n (%) | 58 (28.5) | 50 (24.6) | 0.04 |
Beta-blockers use, n (%) | 108 (53.2) | 107 (52.7) | < 0.01 |
Methimazole use, n (%) | 111 (54.7) | 112 (55.2) | < 0.01 |
Potassium Iodide use, n (%) | 83 (40.9) | 83 (40.9) | 0.01 |
Annual number of patients with thyroid storm per hospital, median [25th–75th percentiles] | 7 [4, 10] | 7 [3, 10] | 0.06 |
Admission number of ICU each day per hospital, median [25th–75th percentiles] | 5.4 [3.3, 7.8] | 5.0 [2.9, 7.8] | 0.01 |
Academic hospital, n (%) | 46 (22.7) | 45 (22.2) | 0.01 |